Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients With Sickle Cell Disease or Other Anemias

NCT02443545 is registered in ClinicalTrials.gov with ApoPharma as lead sponsor.

NCT NCT02443545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02443545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients With Sickle Cell Disease or Other Anemias
Lead sponsor
ApoPharma
Phase
Phase 4
Overall status
Terminated
Start date
May 21, 2015
Completion date
August 21, 2019
Enrollment
134 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

iron overload, other anemias, sickle cell disease